Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits
- PMID: 18097277
- DOI: 10.1097/RLI.0b013e318155aa5a
Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits
Abstract
Objective: Gadofluorine M has been reported to enhance early atherosclerotic plaque signals in magnetic resonance imaging (MRI). The aim of this study was to examine the use of Gadofluorine M to monitor the progression of advanced plaques in a rabbit model.
Methods: Focal advanced atherosclerosis was induced in the right femoral arteries of 6 New Zealand white rabbits using a combination of cholesterol-enriched diet, and sequential air-desiccation, and balloon-overstretch injury. MRI with conventional 3 contrasts (T1, T2, and proton density [PD]) was performed to monitor the progression of the atherosclerotic plaques with 2 MRI scans separated by 4 to 8 weeks. Gadofluorine M was given intravenously to the rabbits 24 hours before the first MRI scans, and before (n = 3) or during (n = 3) the second MRI scan. The left femoral arteries were used as a control. Histopathologic images localized individual plaque components.
Results: The advanced plaque displayed multilayered neointima that included foam cells, smooth muscle cells, and extracellular matrix. The separate image contrasts offered similar T1-weighted enhancement patterns, but the combination of all 3 contrasts helped to delineate plaque and lumen boundaries. Gadofluorine M strongly enhanced neointima areas with an image contrast (contrast-to-noise ratio [CNR]) of approximately 15, versus 2 in the control femoral arterial wall. With improved images, significant changes in neointima and total plaque volumes over the 4 to 8 weeks between scans could be identified. Gadofluorine M remained within the plaques with significant image enhancements (contrast-to-noise ratio = 5.8) for 2 months after a single injection.
Conclusion: This preliminary study in rabbits indicated that Gadofluorine M provides specific enhancements of components associated with advanced atherosclerotic plaques and may help to monitor the progression of the plaque in a rabbit model of atherogenesis.
Similar articles
-
Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging.Circulation. 2004 Jun 15;109(23):2890-6. doi: 10.1161/01.CIR.0000129310.17277.E7. Epub 2004 Jun 7. Circulation. 2004. PMID: 15184290
-
Gadofluorine-enhanced magnetic resonance imaging of carotid atherosclerosis in Yucatan miniswine.Invest Radiol. 2006 Mar;41(3):299-304. doi: 10.1097/01.rli.0000188362.12555.62. Invest Radiol. 2006. PMID: 16481913
-
[MR imaging of lymph nodes using Gadofluorine M: feasibility in a swine model at 1.5 and 3T].Rofo. 2010 Aug;182(8):698-705. doi: 10.1055/s-0029-1245277. Epub 2010 Apr 23. Rofo. 2010. PMID: 20419610 German.
-
Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.J Magn Reson Imaging. 2007 Sep;26(3):460-79. doi: 10.1002/jmri.20989. J Magn Reson Imaging. 2007. PMID: 17729343 Review.
-
Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.Pharmacol Ther. 2006 Apr;110(1):57-70. doi: 10.1016/j.pharmthera.2005.09.004. Epub 2006 Jan 30. Pharmacol Ther. 2006. PMID: 16445985 Review.
Cited by
-
Comparison of gadofluorine-M and Gd-DTPA for noninvasive staging of atherosclerotic plaque stability using MRI.Circ Cardiovasc Imaging. 2009 May;2(3):226-34. doi: 10.1161/CIRCIMAGING.108.826826. Epub 2009 Mar 24. Circ Cardiovasc Imaging. 2009. PMID: 19808597 Free PMC article.
-
Targeted probes for cardiovascular MRI.Future Med Chem. 2010 Mar;2(3):451-70. doi: 10.4155/FMC.09.154. Future Med Chem. 2010. PMID: 20539821 Free PMC article. Review.
-
PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model.J Nucl Med. 2016 Dec;57(12):2006-2011. doi: 10.2967/jnumed.116.172544. Epub 2016 Jul 7. J Nucl Med. 2016. PMID: 27390157 Free PMC article.
-
An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions.Invest Radiol. 2010 Oct;45(10):586-91. doi: 10.1097/RLI.0b013e3181ed1b3b. Invest Radiol. 2010. PMID: 20808239 Free PMC article.
-
Magnetic resonance labeling of stem cells: is positive tracking a plus or a minus?JACC Cardiovasc Imaging. 2009 Sep;2(9):1123-5. doi: 10.1016/j.jcmg.2009.05.010. JACC Cardiovasc Imaging. 2009. PMID: 19761993 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical